The blood brain barrier (BBB) poses a significant challenge for drug delivery of macromolecules into the brain.
Convection-enhanced delivery (CED) circumvents the BBB through direct intracerebral infusion using a hydrostatic pressure
gradient to transfer therapeutic compounds. The efficacy of CED is dependent on the distribution of the therapeutic
agent to the targeted region. Here we present a review of convection enhanced delivery of macromolecules, emphasizing
the role of tracers in enabling effective delivery anddiscuss current challenges in the field.
Keywords: Convection enhanced delivery, drug delivery system, glioblastoma, surrogate markers, tracers, blood brain barrier (BBB), Brain Tumors, macromolecules, surgical resection, radiation therapy
Rights & PermissionsPrintExport
Published on: 02 October, 2012
Page: [305 - 310]